Hideho Okada Selected Research

HLA-A*24:02 antigen

1/2019

Actively personalized vaccination trial for newly diagnosed glioblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hideho Okada Research Topics

Disease

115	Neoplasms (Cancer) 04/2024 - 05/2002
83	Glioma (Gliomas) 02/2024 - 05/2002
40	Glioblastoma (Glioblastoma Multiforme) 04/2024 - 09/2002
26	Brain Neoplasms (Brain Tumor) 04/2024 - 06/2004
7	Central Nervous System Neoplasms 01/2022 - 08/2004
6	Melanoma (Melanoma, Malignant) 11/2013 - 08/2004
3	Ependymoma 01/2018 - 01/2013
3	Astrocytoma (Pilocytic Astrocytoma) 01/2018 - 08/2005
3	Neoplasm Metastasis (Metastasis) 07/2013 - 05/2002
3	Sarcoma (Soft Tissue Sarcoma) 03/2007 - 10/2003
2	Breast Neoplasms (Breast Cancer) 01/2023 - 07/2013
2	Diffuse Intrinsic Pontine Glioma 12/2020 - 01/2018
2	Inflammation (Inflammations) 01/2020 - 11/2015
2	Disease Progression 04/2019 - 06/2012
2	Testicular Neoplasms (Testicular Cancer) 01/2019 - 11/2018
2	Bites and Stings (Sting) 04/2015 - 12/2014
2	Experimental Melanoma 02/2012 - 11/2004
1	Gliosis 01/2023

Drug/Important Bio-Agent (IBA)

49	AntigensIBA 01/2024 - 06/2002
42	VaccinesIBA 01/2024 - 06/2002
26	Peptides (Polypeptides)IBA 01/2022 - 09/2002
18	Chimeric Antigen ReceptorsIBA 04/2024 - 08/2012
18	EpitopesIBA 01/2018 - 09/2002
17	Proteins (Proteins, Gene)FDA Link 01/2024 - 08/2005
12	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 05/2002
8	epidermal growth factor receptor VIIIIBA 04/2024 - 01/2013
8	CytokinesIBA 01/2022 - 10/2003
8	HLA Antigens (Human Leukocyte Antigens)IBA 01/2022 - 08/2005
8	Interleukin-4 (Interleukin 4)IBA 10/2009 - 12/2002
7	Protein Subunit VaccinesIBA 12/2022 - 11/2009
7	Biomarkers (Surrogate Marker)IBA 12/2022 - 09/2002
7	poly ICLCIBA 01/2022 - 02/2007
7	Messenger RNA (mRNA)IBA 01/2018 - 01/2007
7	Monoclonal AntibodiesIBA 12/2014 - 02/2007
6	Lysine (L-Lysine)FDA Link 01/2018 - 02/2007
6	gallium arsenide (GaAs)IBA 12/2016 - 12/2007
6	Integrin alpha4beta1 (VLA-4)IBA 10/2009 - 02/2007
5	AntibodiesIBA 01/2024 - 08/2011
5	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 12/2023 - 04/2017
5	Carboxymethylcellulose Sodium (Polycell)FDA Link 07/2014 - 02/2007
5	OvalbuminIBA 07/2007 - 08/2004
4	Therapeutic UsesIBA 01/2024 - 05/2002
4	RNA (Ribonucleic Acid)IBA 01/2024 - 06/2012
4	Immune Checkpoint InhibitorsIBA 01/2021 - 11/2013
4	ChemokinesIBA 04/2017 - 02/2008
4	LigandsIBA 10/2016 - 02/2007
4	SurvivinIBA 01/2016 - 01/2007
4	Poly I-CIBA 07/2014 - 09/2009
4	InterferonsIBA 01/2012 - 08/2004
3	ErbB Receptors (EGF Receptor)IBA 01/2023 - 09/2005
3	dipinacoline glutamateIBA 12/2022 - 01/2018
3	FluorineIBA 01/2021 - 01/2013
3	FluorocarbonsIBA 01/2021 - 01/2013
3	Cancer VaccinesIBA 12/2015 - 02/2009
3	Celecoxib (Celebrex)FDA Link 08/2014 - 04/2011
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 08/2014 - 04/2011
3	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 08/2014 - 05/2013
3	Histocompatibility Antigens Class IIBA 06/2012 - 01/2007
3	HLA-A2 Antigen (HLA A2 Antigen)IBA 02/2012 - 06/2006
3	MicroRNAs (MicroRNA)IBA 02/2012 - 06/2009
3	InterleukinsIBA 12/2007 - 07/2003
3	Interleukin-13 Receptor alpha2 SubunitIBA 01/2007 - 09/2002
3	Complementary DNA (cDNA)IBA 04/2006 - 07/2003
2	Adenosine Triphosphate (ATP)IBA 02/2024 - 11/2023
2	Surface Antigens (Surface Antigen)IBA 01/2024 - 11/2023
2	Protein Isoforms (Isoforms)IBA 01/2024 - 11/2023
2	IMA950IBA 09/2023 - 01/2018
2	Temozolomide (Temodar)FDA LinkGeneric 01/2021 - 08/2011
2	Oxygen (Dioxygen)IBA 01/2021 - 01/2013
2	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2020 - 06/2016
2	AcidsIBA 01/2019 - 10/2003
2	ProteomeIBA 01/2019 - 11/2018
2	HLA-A Antigens (HLA-A)IBA 01/2019 - 07/2012
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2016 - 04/2006
2	EnzymesIBA 11/2015 - 12/2007
2	Antiviral Agents (Antivirals)IBA 12/2014 - 01/2012
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 11/2013 - 03/2007
2	Interferon Type IIBA 05/2013 - 07/2003
2	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 07/2012 - 09/2002
2	Transforming Growth Factor beta (TGF-beta)IBA 11/2009 - 08/2003
2	Fas Ligand Protein (Fas Ligand)IBA 08/2005 - 08/2003
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2005 - 11/2004
1	Zidovudine (Retrovir)FDA LinkGeneric 04/2024
1	RNA Splicing FactorsIBA 10/2023
1	varlilumabIBA 09/2023
1	Thrombospondin 1IBA 08/2023
1	9-(4-fluoro-3-hydroxymethylbutyl)guanineIBA 01/2023
1	human ERBB2 proteinIBA 01/2023
1	N,N- diethyl- 2- (2- (4- (2- fluoroethoxy)phenyl)- 5,7- dimethylpyrazolo(1,5- a)pyrimidin- 3- yl)acetamideIBA 01/2023
1	alpha-hydroxyglutarateIBA 01/2022
1	Mutant Proteins (Protein, Mutant)IBA 01/2022
1	Myelin-Oligodendrocyte GlycoproteinIBA 01/2021

Therapy/Procedure

73	Immunotherapy 01/2024 - 08/2003
53	Therapeutics 04/2024 - 05/2002
8	Drug Therapy (Chemotherapy) 12/2022 - 08/2011
7	Radiotherapy 12/2022 - 12/2007
4	Intravenous Infusions 02/2024 - 01/2021
4	Injections 09/2010 - 07/2003
2	Chemoradiotherapy 04/2024 - 01/2020
1	Combined Modality Therapy 01/2021